Bill

Bill > LB5


NE LB5

NE LB5
Provide immunity for administration of naloxone or other federally approved opioid antagonists


summary

Introduced
01/09/2025
In Committee
01/13/2025
Crossed Over
Passed
Dead

Introduced Session

109th Legislature

Bill Summary

A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to amend section 28-470, Revised Statutes Cumulative Supplement, 2024; to provide for immunity for conduct relating to opioid antagonists; to provide and eliminate definitions; and to repeal the original section.

AI Summary

This bill expands legal protections for individuals and professionals who administer opioid antagonists (medications like naloxone that can rapidly reverse opioid overdose) in emergency situations. The bill broadens the existing law to cover not just naloxone specifically, but any opioid antagonist approved by the U.S. Food and Drug Administration for reversing opioid overdoses. It provides immunity from criminal prosecution, administrative action, and civil liability for health professionals, emergency responders, law enforcement personnel, and family members or friends who obtain and administer these medications in good faith to help someone experiencing an apparent opioid overdose. The protections apply as long as the person acts reasonably and is not willfully, wantonly, or grossly negligent. The bill defines key terms like "emergency responder" and "health professional" and clarifies that the immunity extends to obtaining the medication from a professional, administering it, and potentially not arranging further medical treatment, with the caveat that the person or their agency can still be held liable for intentionally harmful actions.

Committee Categories

Justice

Sponsors (1)

Last Action

Title printed. Carryover bill (on 01/07/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...